Hypereosinophilic syndrome: The hypereosinophilic syndrome (HES) is a disease characterized by a persistently elevated eosinophil count (≥ 1500 eosinophils/mm³) in the blood for at least six months without any recognizable cause, with involvement of either the heart, nervous system, or bone marrow. HES is a diagnosis of exclusion, after clonal eosinophilia (such as leukemia) and reactive eosinophilia (in response to infection, autoimmune disease, atopy, hypoadrenalism, tropical eosinophilia, or cancer) have been ruled out.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
2487 |
4. Check minimum number of eventsNone |
2487 |
5. Include endpoints |
2627 |
6. Filter based on genotype QC (FinnGen only) |
2114 |
Control definitions (FinnGen only)
- Control exclude
- D3_BLOODOTHER
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D70-D77
- Name in latin
- Aliae morbositates leucocytorum
Similar endpoints
↥List of similar endpoints to
Other disorders of white blood cells
based on the number of shared cases.
Similar with more cases:
- Other diseases of blood and blood-forming organs, wide
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 15172 | 7959 | 7095 |
| Only index persons | 12791 | 6804 | 5987 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.21 | 0.23 | 0.20 |
| Only index persons | 0.24 | 0.25 | 0.23 |
| Median age at first event (years) | |||
| Whole population | 58.28 | 57.40 | 59.16 |
| Only index persons | 56.26 | 54.92 | 57.78 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2114 | 1137 | 977 |
| Unadjusted period prevalence (%) | 0.42 | 0.40 | 0.45 |
| Median age at first event (years) | 57.53 | 53.10 | 62.68 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2221
- Matched controls
- 22210
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
44.2
307.7
262
67
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
1785.7
307.7
1250
16
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
11.9
307.7
386
386
XW000
NOMESCO Finland
Bone marrow biopsy
23.5
307.7
626
365
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
295.9
307.7
328
13
D72.1
ICD-10 Finland
Eosinophilia
3861.1
307.7
600
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
49.0
288.1
168
37
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
27.4
226.8
156
61
D70.89
ICD-10 Finland
Neutropenic splenomegaly
109.1
202.4
104
10
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.2
177.1
601
1812
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
67.1
153.2
84
13
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
111.6
1372
8274
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
30.9
105.1
69
23
L01XX05
ATC
hydroxycarbamide; oral
13.6
104.6
99
76
189
Kela drug reimbursment
Imatinib
39.0
92.7
57
15
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.7
92.7
233
545
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
29.3
89.9
60
21
R50.9
ICD-10 Finland
Fever, unspecified
2.8
85.7
519
2147
2888B
ICD-9 Finland
Diseases of white blood cells, Other specified disease of white blood cells[LEUCOPENIA]
+∞
81.8
78
*
H02AB06
ATC
prednisolone; systemic
2.3
81.6
1258
7968
L01XE01
ATC
[U] imatinib
40.9
79.0
48
12
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
43.6
78.6
47
11
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
69.9
372
1423
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
69.0
750
4033
M04AA01
ATC
allopurinol; systemic
2.7
67.6
424
1767
L03AA02
ATC
filgrastim; parenteral
5.5
65.5
130
247
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
11.9
64.7
66
57
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
7.2
64.7
98
142
H02AB09
ATC
hydrocortisone; systemic
5.6
59.1
116
218
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.9
57.5
308
1176
J32.4
ICD-10 Finland
Chronic pansinusitis
7.1
57.4
88
129
WW500
NOMESCO Finland
Blood transfusion
4.3
56.1
153
379
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
55.0
300
1155
J45.9
ICD-10 Finland
Asthma, unspecified
2.3
53.9
532
2706
JN4BD
NOMESCO Finland
Extensive body CT
2.8
53.7
312
1241
J01MA12
ATC
levofloxacin; systemic
2.3
53.3
519
2623
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
52.9
848
5187
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.2
52.5
223
744
TGC00
NOMESCO Finland
Bronchial lavation
5.0
51.1
112
232
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
9.6
50.8
60
64
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
15.5
50.3
44
29
R03BB04
ATC
tiotropium bromide; inhalant
2.6
48.6
312
1302
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.4
48.6
188
592
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.9
46.9
245
918
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
14.1
46.8
43
31
127
Kela drug reimbursment
Transplant complication
6.3
43.9
74
120
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
43.7
743
4572
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.1
43.0
121
306
D64.9
ICD-10 Finland
Anaemia, unspecified
2.5
42.8
318
1418
J45.1
ICD-10 Finland
Nonallergic asthma
2.9
42.7
222
829
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.8
42.7
232
887
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.8
41.8
227
867
D70.82
ICD-10 Finland
Drug-induced neutropenia
404.7
40.2
40
*
A02BC02
ATC
pantoprazole; systemic
1.9
39.9
1572
12451
C91.7
ICD-10 Finland
Other lymphoid leukaemia
142.6
39.9
42
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
58.7
39.4
46
8
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
64.1
38.2
44
7
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.0
38.0
504
2828
R03DC03
ATC
montelukast; oral
2.1
37.9
421
2213
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.2
37.7
103
255
J01MA14
ATC
moxifloxacin; systemic
2.5
37.5
259
1113
ZXE00
NOMESCO Finland
One hour or less
1.8
37.5
915
6238
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
37.3
1204
8898
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.4
37.3
286
1290
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.3
37.0
145
459
R03AK08
ATC
formoterol and beclometasone; inhalant
3.2
36.8
149
481
ZX112
NOMESCO Finland
Subcutaneous
4.8
36.8
85
184
C03CA01
ATC
furosemide; systemic
1.8
36.8
729
4661
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
54.8
36.5
43
8
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.6
36.2
123
355
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
35.8
444
2425
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
52.2
34.5
41
8
ZX120
NOMESCO Finland
Intravenous
2.4
34.4
254
1124
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
4.1
34.4
95
237
WW200
NOMESCO Finland
Immunization
4.0
34.0
98
252
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
75.4
32.9
37
5
L01EA01
ATC
imatinib; oral
45.2
32.8
40
9
JN4AD
NOMESCO Finland
Body CT examination
2.2
32.3
311
1539
Z3231
NOMESCO Finland
Registered nurse
1.8
31.7
638
4063
J01DB01
ATC
cefalexin; oral
2.0
31.6
1849
15875
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
31.5
546
3321
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.4
31.5
242
1089
GD1AD
NOMESCO Finland
Thorax CT examination
2.6
31.2
188
755
L04AA06
ATC
mycophenolic acid; systemic
4.7
31.2
73
160
Z2221
NOMESCO Finland
Medical doctor
1.8
31.1
641
4109
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.9
31.0
154
559
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
10.1
31.0
35
35
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
3.8
30.9
98
270
R03AC02
ATC
salbutamol; inhalant
1.7
30.7
1232
9455
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
30.0
817
5650
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
12.2
29.9
30
25
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
29.8
472
2784
A41.9
ICD-10 Finland
Sepsis, unspecified
3.3
29.8
113
350
JN6AD
NOMESCO Finland
CT of torso and neck
4.9
29.8
66
138
H02AB07
ATC
prednisone; oral
2.1
29.6
334
1754
UJF30
NOMESCO Finland
Ileoscopy through colon
2.2
29.0
275
1350
A05AA02
ATC
ursodeoxycholic acid; oral
5.0
28.9
62
126
A04AA01
ATC
ondansetron; systemic, rectal
2.4
28.3
218
980
D72.0
ICD-10 Finland
Genetic anomalies of leukocytes
+∞
28.2
27
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
5.3
28.0
56
107
L04AD01
ATC
ciclosporin; systemic
4.6
27.2
64
141
B73
ICPC
Leukaemia
46.3
26.5
32
7
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
26.5
593
3862
316
Kela drug reimbursment
Imatinib
52.3
26.2
31
6
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
26.1
245
1196
J33.0
ICD-10 Finland
Polyp of nasal cavity
3.4
26.0
96
293
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
25.9
536
3410
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
25.8
560
3612
XG474
NOMESCO Finland
Exhalation nntrogen oxide
3.6
25.6
85
242
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
28.7
25.4
34
12
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.5
25.3
167
700
A02BC01
ATC
omeprazole; systemic
1.7
25.2
607
4025
R4110
NOMESCO Finland
Physiotherapy
1.7
24.7
635
4278
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
24.3
799
5723
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
2.7
23.9
136
530
D45
ICD-10 Finland
Polycythaemia vera
6.4
23.6
39
62
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
23.5
436
2681
R06.0
ICD-10 Finland
Dyspnoea
1.7
23.2
632
4311
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
23.1
434
2675
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
23.1
412
2501
L01XX52
ATC
venetoclax; oral
24.9
23.1
32
13
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
22.9
267
1411
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.3
22.8
173
772
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.6
22.7
136
544
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
22.5
533
3503
J01AA02
ATC
doxycycline; systemic
1.7
22.2
1674
14427
J01FF01
ATC
clindamycin; systemic
1.6
22.1
598
4063
B03XA02
ATC
darbepoetin alfa; parenteral
3.6
22.0
72
203
R06AE07
ATC
cetirizine; oral
1.6
21.9
923
6960
JN3AD
NOMESCO Finland
Abdominal CT examination
1.9
21.9
311
1757
D75.2
ICD-10 Finland
Essential thrombocytosis
63.2
21.9
25
*
H02AB04
ATC
methylprednisolone; systemic
1.9
21.8
327
1880
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.4
21.8
158
691
R03BA08
ATC
ciclesonide; inhalant
2.1
21.8
212
1048
399
Kela drug reimbursment
Venetoclax
22.4
21.7
31
14
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.8
21.4
331
1921
L04AX01
ATC
azathioprine; systemic
2.8
21.1
110
410
E0000UV, ,
ATC
1.5
21.1
901
6802
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.3
21.0
174
805
UJF32
NOMESCO Finland
Coloscopy
1.6
21.0
578
3936
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
8.5
21.0
27
32
3028
Kela drug reimbursment
Mepolizumab
60.6
20.9
24
*
ZX108
NOMESCO Finland
Inhalation
6.9
20.8
32
47
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
20.5
359
2161
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
6.6
20.5
33
51
J45.8
ICD-10 Finland
Mixed asthma
3.1
20.4
87
290
Z2446
NOMESCO Finland
Social worker
2.3
20.3
167
771
N02AX02
ATC
tramadol; systemic, rectal
1.5
20.0
925
7080
R03DX09
ATC
mepolizumab; parenteral
58.1
19.9
23
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.9
19.9
94
332
A07AA02
ATC
nystatin; oral
2.4
19.9
143
623
R03BA05
ATC
fluticasone; inhalant
1.7
19.9
402
2522
212
Kela drug reimbursment
Gout
3.8
19.8
61
165
Z3226
NOMESCO Finland
Physiotherapist
1.7
19.8
408
2573
A46
ICD-10 Finland
Erysipelas
1.8
19.8
343
2059
J46
ICD-10 Finland
Status asthmaticus
3.2
19.6
77
244
L01BB05
ATC
fludarabine; systemic
40.5
19.5
24
6
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
19.3
269
1507
J01MA02
ATC
ciprofloxacin; systemic
1.5
19.2
836
6298
1512
Kela drug reimbursment
Ibrutinib
26.3
19.1
26
10
390
Kela drug reimbursment
Ibrutinib
26.3
19.1
26
10
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
19.1
218
1142
J45
ICD-10 Finland
Asthma
1.9
19.1
241
1308
R05
ICD-10 Finland
Cough
1.6
19.0
478
3171
297, ,
Kela drug reimbursment
55.5
18.9
22
*
L04AX03
ATC
methotrexate; systemic
2.0
18.8
225
1199
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.6
18.5
61
173
A03FA01
ATC
metoclopramide; systemic, rectal
1.6
18.3
473
3156
XQ800
NOMESCO Finland
Prick test
2.2
18.3
165
791
N05CF01
ATC
zopiclone; oral
1.5
18.2
672
4875
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
21.9
18.2
26
12
J01CA04
ATC
amoxicillin; systemic
1.6
18.1
1759
15595
WX402
NOMESCO Finland
General anaesthesia
1.6
18.1
492
3323
D07AB08
ATC
desonide; topical
1.9
17.9
241
1334
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
17.9
1024
8129
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
7.0
17.8
27
39
152
Kela drug reimbursment
Nilotinib
67.2
17.7
20
*
2888A
ICD-9 Finland
Diseases of white blood cells, Other specified disease of white blood cells[LEUCOCYTOSIS]
+∞
17.7
17
*
2883X
ICD-9 Finland
Diseases of white blood cells, Eosinophilia[EOSINOPHILIA, NUD]
+∞
17.7
17
*
J05AB11
ATC
valaciclovir; oral
1.8
17.7
324
1971
R53
ICD-10 Finland
Malaise and fatigue
1.6
17.7
554
3868
R01AD08
ATC
fluticasone; nasal
1.6
17.5
588
4171
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.9
17.3
244
1371
L01AA02
ATC
chlorambucil; oral
18.8
17.3
26
14
1518, ,
Kela drug reimbursment
18.8
17.3
26
14
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
3.2
17.3
67
211
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
17.2
354
2223
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.0
17.2
77
264
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
4.4
17.1
42
96
D07AC01
ATC
betamethasone; topical
1.5
17.1
768
5793
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.9
17.0
82
293
R02
ICPC
Shortness of breath/dyspnoea
1.7
17.0
312
1900
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
16.8
429
2850
R03AK11
ATC
formoterol and fluticasone; inhalant
3.0
16.7
72
242
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.9
16.4
225
1253
J01FA09
ATC
clarithromycin; systemic
1.5
16.3
641
4692
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.6
16.2
93
364
DPA30
NOMESCO Finland
Sphenotomy
6.0
16.1
28
47
L01EL01
ATC
ibrutinib; oral
47.9
16.0
19
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
18.6
16.0
24
13
D07AB02
ATC
hydrocortisone butyrate; topical
1.5
16.0
614
4469
WZC00
NOMESCO Finland
Treatment plan or consultation
1.5
15.9
791
6067
ZXD05
NOMESCO Finland
Urgent procedure
1.5
15.7
631
4632
L04AA01
ATC
[U] ciclosporin
4.3
15.5
40
95
J01FA10
ATC
azithromycin; systemic
1.4
15.5
1163
9623
A03
ICPC
Fever
1.6
15.4
364
2367
L04AD02
ATC
tacrolimus; systemic
4.6
15.2
36
80
XF600
NOMESCO Finland
Bloodpressure measurement
2.1
15.2
149
738
WX892
NOMESCO Finland
Monitored bed care
2.0
15.2
181
962
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
6.1
15.1
26
43
P01AB01
ATC
metronidazole; oral, rectal
1.5
15.1
811
6298
J33.8
ICD-10 Finland
Other polyp of sinus
3.1
15.0
61
198
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
15.0
443
3038
M05BA04
ATC
alendronic acid; oral
1.9
14.9
183
981
J02AC03
ATC
voriconazole; systemic
15.1
14.9
24
16
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
31.9
14.8
19
6
A02BC05
ATC
esomeprazole; systemic
1.4
14.6
829
6491
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
14.5
286
1771
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.0
14.4
41
105
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
14.4
598
4409
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.6
14.3
85
339
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.7
14.3
75
281
B03XA01
ATC
erythropoietin; parenteral
4.9
14.3
31
64
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
14.2
864
6842
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
4.1
14.2
38
93
DHB20
NOMESCO Finland
Polypectomy of internal nose
3.6
14.2
47
134
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.2
14.1
55
174
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.0
14.1
148
751
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
14.1
289
1809
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.0
14.1
148
752
XG410
NOMESCO Finland
Flow-volume spirometry
2.4
14.0
95
403
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
4.8
14.0
31
65
R05
ICPC
Cough
1.5
14.0
528
3814
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.0
13.9
61
207
C07AB07
ATC
bisoprolol; oral
1.4
13.9
1020
8341
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.1
13.9
135
666
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
13.9
901
7213
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
17.7
13.8
21
12
L01XX28
ATC
[U] imatinib
53.7
13.8
16
*
SPAT1263
SPAT
Sampling
1.4
13.7
847
6714
ZY010
NOMESCO Finland
Hospital outpatient
2.2
13.6
118
557
328
Kela drug reimbursment
Nilotinib
75.6
13.6
15
*
7806A
ICD-9 Finland
General symptoms, Pyrexia of unknown origin
4.8
13.5
30
63
N05BA01
ATC
diazepam; systemic, rectal
1.7
13.5
269
1670
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
13.5
188
1052
I50.9
ICD-10 Finland
Heart failure, unspecified
1.7
13.5
299
1910
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.4
13.5
95
411
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.1
13.4
126
614
D75.1
ICD-10 Finland
Secondary polycythaemia
25.9
13.4
18
7
WZC30
NOMESCO Finland
Teaching
1.6
13.3
358
2396
SPAT1254
SPAT
Administration of medicine
1.6
13.3
308
1988
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.5
13.2
82
335
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
40.3
13.2
16
*
SPAT1262
SPAT
Handing over of treatment supplies
1.6
13.1
360
2422
WX002
NOMESCO Finland
Sedation and analgesia
1.6
13.1
398
2741
ZXA10
NOMESCO Finland
Bilateral
1.6
13.0
375
2549
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.8
13.0
184
1034
SPAT1255
SPAT
Intravenous administration of medicine
2.0
13.0
150
788
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
13.0
380
2593
N03AX16
ATC
[U] pregabalin
1.5
12.9
465
3319
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.8
12.9
62
222
N05BA04
ATC
oxazepam; oral
1.5
12.8
533
3915
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
5.4
12.8
25
47
R03AC12
ATC
salmeterol; inhalant
2.3
12.7
99
447
N06AB04
ATC
citalopram; systemic
1.5
12.7
412
2874
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
70.3
12.6
14
*
150
Kela drug reimbursment
Dasatinib
70.3
12.6
14
*
L01EA03
ATC
nilotinib; oral
70.3
12.6
14
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
32.2
12.6
16
5
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.1
12.5
115
555
R03AK07
ATC
formoterol and budesonide; inhalant
1.5
12.4
429
3032
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.8
12.4
191
1102
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
4.7
12.4
28
60
UJF92
NOMESCO Finland
Capsular endoscopy
3.0
12.3
55
189
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.1
12.3
115
560
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
14.4
12.3
20
14
S97
ICPC
Chronic ulcer skin
1.9
12.2
146
777
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
12.1
242
1504
RS220, ,
NOMESCO Finland
3.7
12.1
38
105
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.2
12.0
97
445
R60.0
ICD-10 Finland
Localized oedema
1.6
12.0
272
1744
N06AX16
ATC
venlafaxine; oral
1.6
12.0
287
1865
N02BE01
ATC
paracetamol; systemic, rectal
1.6
12.0
1909
17680
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.8
11.9
58
209
R01AD09
ATC
mometasone; nasal
1.4
11.9
896
7296
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
46.9
11.9
14
*
N02AA05
ATC
oxycodone; systemic
1.5
11.8
384
2676
N03AE01
ATC
clonazepam; systemic
2.0
11.8
122
616
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
4.0
11.7
33
84
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
4.0
11.7
33
84
N05AA02
ATC
levomepromazine; systemic
2.3
11.7
87
385
R06.2
ICD-10 Finland
Wheezing
2.2
11.7
104
496
E000001, ,
ATC
1.5
11.7
388
2718
J02AC01
ATC
fluconazole; systemic
1.4
11.6
742
5873
T90
ICPC
Diabetes non-insulin dependent
1.5
11.6
508
3759
R03BA02
ATC
budesonide; inhalant
1.5
11.6
361
2493
L28
ICPC
Limited function/disability (L)
1.5
11.6
400
2824
Z88.6
ICD-10 Finland
Personal history of allergy to analgesic agent
19.0
11.6
17
9
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
3.6
11.6
38
108
9101
FHL
Bone biopsy
23.0
11.6
16
7
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.0
11.6
128
663
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.0
11.5
121
615
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
11.5
322
2171
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
11.5
271
1755
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.2
11.5
99
467
D72
ICD-10 Finland
Other disorders of white blood cells
+∞
11.5
11
*
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
2.8
11.5
55
197
N07BA03
ATC
varenicline; oral
2.2
11.4
101
481
AA1AD
NOMESCO Finland
CT of head and brain
1.4
11.4
603
4618
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.3
11.4
41
124
UDC00
NOMESCO Finland
Ear microscopy
1.9
11.4
157
876
R96
ICPC
Asthma
1.7
11.3
209
1269
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
3.6
11.3
36
100
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.2
11.3
95
443
R01AD12
ATC
fluticasone furoate; nasal
1.4
11.3
612
4705
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
11.3
875
7143
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
10.6
11.3
21
20
E000002, ,
ATC
1.7
11.2
217
1335
318
Kela drug reimbursment
Teriparatide
5.6
11.2
21
38
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
11.1
271
1768
120
Kela drug reimbursment
Hypogammaglobulinaemia
20.1
11.1
16
8
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.7
11.1
57
212
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.3
11.0
82
364
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
13.9
11.0
18
13
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.2
10.9
86
391
J47
ICD-10 Finland
Bronchiectasis
3.0
10.9
48
164
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.1
10.9
108
538
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.3
10.9
84
379
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
10.7
389
2770
T78.4
ICD-10 Finland
Allergy, unspecified
2.2
10.7
92
433
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.9
10.7
140
767
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.3
10.7
84
381
1XC02, ,
NOMESCO Finland
4.7
10.7
24
51
P01BA02
ATC
hydroxychloroquine; oral
1.8
10.7
165
952
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
5.6
10.7
20
36
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.8
10.7
176
1036
C03DA01
ATC
spironolactone; oral
1.6
10.7
255
1656
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
10.6
1486
13237
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
60.3
10.6
12
*
L01XE06
ATC
[U] dasatinib
60.3
10.6
12
*
B01AA03
ATC
warfarin; systemic
1.5
10.6
368
2598
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
11.3
10.5
19
17
A06AD11
ATC
lactulose; oral
1.6
10.5
295
1988
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
3.7
10.5
33
91
R11
ICD-10 Finland
Nausea and vomiting
1.7
10.5
183
1094
R55
ICD-10 Finland
Syncope and collapse
1.6
10.5
230
1462
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.6
10.4
245
1584
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.4
10.4
492
3684
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
3.0
10.4
44
147
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.1
10.3
97
473
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.1
10.3
42
137
N05AH02
ATC
clozapine; systemic
3.1
10.3
42
137
L01XE27
ATC
[U] ibrutinib
32.7
10.3
13
*
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
3.4
10.3
36
107
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
10.2
206
1281
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
2.7
10.2
52
193
L01AA01
ATC
cyclophosphamide; systemic
7.5
10.2
23
31
J01FA06
ATC
roxithromycin; oral
1.4
10.1
778
6313
B01AB10
ATC
tinzaparin; parenteral
1.6
10.1
225
1435
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
10.1
743
5988
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.4
10.0
498
3759
N03AX09
ATC
lamotrigine; oral
2.1
10.0
99
493
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.3
9.9
73
323
R4120
NOMESCO Finland
Occupational therapy
1.8
9.9
138
773
N06AX11
ATC
mirtazapine; oral
1.4
9.9
676
5384
R03DA04
ATC
theophylline; systemic, rectal
2.0
9.9
104
530
N18.8
ICD-10 Finland
Other chronic renal failure
2.6
9.8
56
220
R03DX10
ATC
benralizumab; systemic
26.1
9.8
13
5
3027
Kela drug reimbursment
Benralizumab
26.1
9.8
13
5
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
8.8
9.8
20
23
B99
ICPC
Blood/lymph/spleen disease other
8.8
9.8
20
23
D11AH05
ATC
dupilumab; topical
10.7
9.8
18
17
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
2.6
9.8
54
209
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
9.6
9.8
19
20
D07AA02
ATC
hydrocortisone; topical
1.6
9.7
266
1781
A01AB09
ATC
miconazole; local oral
1.7
9.7
167
994
R4190
NOMESCO Finland
Nutritional therapy
2.1
9.7
90
438
J20
ICD-10 Finland
Acute bronchitis
1.6
9.7
206
1300
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.7
9.7
191
1182
L01XE08
ATC
[U] nilotinib
55.2
9.6
11
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
2.2
9.6
80
372
D02AX
ATC
Other emollients and protectives
2.4
9.6
67
289
R03DC01
ATC
zafirlukast; oral
3.2
9.6
38
122
R52.9
ICD-10 Finland
Pain, unspecified
1.6
9.5
211
1345
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.9
9.5
118
637
R03BA01
ATC
beclometasone; inhalant
1.6
9.5
266
1792
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.5
9.5
370
2670
R20.2
ICD-10 Finland
Paraesthesia of skin
1.8
9.5
142
813
J33.9
ICD-10 Finland
Nasal polyp, unspecified
3.3
9.4
34
103
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
9.4
220
1419
B84
ICPC
Unexplained abnormal white cells
100.5
9.4
10
*
A07EA06
ATC
budesonide; oral, local oral
2.2
9.4
77
357
B01AB05
ATC
enoxaparin; parenteral
1.4
9.3
616
4869
D07AD01
ATC
clobetasol; topical
1.5
9.3
323
2275
Z51.5
ICD-10 Finland
Palliative care
1.7
9.3
179
1099
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.1
9.3
85
411
H65.3
ICD-10 Finland
Chronic mucoid otitis media
2.8
9.2
46
169
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
9.2
519
3998
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
13.7
9.2
15
11
L50.0
ICD-10 Finland
Allergic urticaria
2.5
9.1
57
234
XX3DW
NOMESCO Finland
Time consuming IT work
1.6
9.1
217
1408
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
3.5
9.1
30
86
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.7
9.1
158
945
395
Kela drug reimbursment
Dupilumab
11.5
9.1
16
14
G47.3
ICD-10 Finland
Sleep apnoea
1.4
9.1
455
3436
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
2.1
9.0
88
436
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
9.0
275
1886
C95.9
ICD-10 Finland
Leukaemia, unspecified
36.8
9.0
11
*
A10AB05
ATC
insulin aspart; parenteral
1.7
9.0
158
947
103
Kela drug reimbursment
Diabetes, insulin-treated
1.4
8.9
534
4151
N05CD07
ATC
temazepam; oral
1.6
8.9
223
1463
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.8
8.9
135
776
J05AB01
ATC
aciclovir; systemic
1.4
8.9
425
3181
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
4.3
8.9
22
51
ZXA05
NOMESCO Finland
Left side
1.4
8.9
470
3581
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
8.8
277
1911
R03AC13
ATC
formoterol; inhalant
1.9
8.8
103
545
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.8
8.8
134
771
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.8
8.8
143
839
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
3.3
8.8
32
98
N05AH04
ATC
quetiapine; oral
1.5
8.8
341
2457
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.3
8.8
65
289
R51.80
ICD-10 Finland
Headache
1.5
8.7
304
2142
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
50.2
8.7
10
*
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.9
8.7
101
534
A02BC03
ATC
lansoprazole; oral
1.4
8.7
549
4305
C83.1
ICD-10 Finland
Mantle cell lymphoma
7.7
8.6
19
25
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.8
8.6
118
657
PJA10
NOMESCO Finland
Exploration of lymph nodes
3.4
8.6
30
89
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
3.3
8.6
31
94
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
3.2
8.5
33
105
Z3229
NOMESCO Finland
Other healthcare associate professional
1.7
8.5
163
1001
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.7
8.5
44
165
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
8.5
121
683
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
8.4
73
346
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.2
8.4
69
320
D73.1
ICD-10 Finland
Hypersplenism
90.4
8.4
9
*
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.1
8.4
76
367
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.8
8.3
125
716
Z85.6
ICD-10 Finland
Personal history of leukaemia
+∞
8.3
8
*
9831/3-C42.1
ICD-O-3
T-cell large granular lymphocytic leukemia of bone marrow
+∞
8.3
8
*
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.0
8.3
23
58
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
4.1
8.3
22
54
TPH00
NOMESCO Finland
Phlebotomy
7.1
8.2
19
27
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
8.2
309
2209
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.9
8.2
99
529
RD210, ,
NOMESCO Finland
2.8
8.2
40
145
S18
ICPC
Laceration/cut
1.3
8.2
963
8232
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
3.3
8.2
30
92
A28
ICPC
Limited function/disability NOS
1.4
8.2
358
2633
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
14.5
8.2
13
9
TAB00
NOMESCO Finland
Lumbar puncture
1.9
8.2
95
502
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.6
8.1
218
1455
Z31.5
ICD-10 Finland
Genetic counselling
1.9
8.1
99
533
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
8.1
164
1023
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.1
8.0
72
346
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.8
8.0
40
147
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
2.6
8.0
45
176
374
Kela drug reimbursment
Ruxolitinib
22.1
8.0
11
5
251, ,
Kela drug reimbursment
22.1
8.0
11
5
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.6
8.0
188
1215
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.7
8.0
131
771
XG405
NOMESCO Finland
Education on PEF monitoring
2.9
8.0
35
120
D68.8
ICD-10 Finland
Other specified coagulation defects
3.5
8.0
26
74
A11CC03
ATC
alfacalcidol; systemic
2.4
8.0
54
231
I51.4
ICD-10 Finland
Myocarditis, unspecified
4.3
7.9
20
47
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
7.9
573
4576
L29.9
ICD-10 Finland
Pruritus, unspecified
2.2
7.9
63
289
J01DA01
ATC
[U] cefalexin
1.3
7.9
1219
10779
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.6
7.9
196
1284
D07AC13
ATC
mometasone; topical
1.3
7.9
549
4361
R81
ICPC
Pneumonia
2.0
7.8
82
418
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
3.0
7.8
34
116
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.4
7.8
53
227
DHA10
NOMESCO Finland
Biopsy of cavity of nose
3.8
7.8
23
61
Z94.0
ICD-10 Finland
Kidney transplant status
3.3
7.8
28
85
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.6
7.7
201
1330
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.6
7.7
187
1217
TQW99
NOMESCO Finland
Other minor procedure on skin
1.8
7.7
105
584
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.2
7.7
60
273
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.2
7.7
60
273
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.2
7.7
62
286
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
7.7
542
4310
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.8
7.7
106
593
R06AX22
ATC
ebastine; oral
1.4
7.6
311
2257
SPAT1260
SPAT
Consultation of another employee
1.4
7.6
325
2379
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
4.0
7.6
21
53
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
4.0
7.6
21
53
Z2445
NOMESCO Finland
Psychologist
2.0
7.6
78
395
6BA02, ,
NOMESCO Finland
8.0
7.6
16
20
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.1
7.6
67
321
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.6
7.5
178
1152
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
3.3
7.5
27
82
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
3.3
7.5
27
82
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.3
7.5
557
4460
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
2.8
7.5
36
130
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
4.3
7.5
19
45
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
4.3
7.5
19
45
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
2.6
7.5
41
159
Z49.1
ICD-10 Finland
Extracorporeal dialysis
2.9
7.4
33
114
D69.4
ICD-10 Finland
Other primary thrombocytopenia
80.4
7.4
8
*
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
80.4
7.4
8
*
N05AF03
ATC
chlorprothixene; systemic
2.3
7.4
51
220
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.2
7.4
59
271
E000003, ,
ATC
1.9
7.4
84
441
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
2.8
7.4
36
131
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
13.4
7.4
12
9
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
6.0
7.4
19
32
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
6.0
7.4
19
32
L01BA01
ATC
methotrexate; systemic
2.1
7.4
69
338
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.5
7.3
220
1504
L03AA13
ATC
pegfilgrastim; parenteral
1.9
7.3
82
429
D73.5
ICD-10 Finland
Infarction of spleen
+∞
7.3
7
*
2888X
ICD-9 Finland
Diseases of white blood cells, Other specified disease of white blood cells[LEUCOCYTOPATHIA ALIA DEFINITA]
+∞
7.3
7
*
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
7.3
7
*
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
2.3
7.3
55
247
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
2.6
7.3
40
155
J31.0
ICD-10 Finland
Chronic rhinitis
1.6
7.3
162
1034
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
2.4
7.3
46
191
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.7
7.3
37
138
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
7.2
506
4013
A01AB04
ATC
amphotericin B; local oral
1.9
7.2
87
466
H05AA02
ATC
teriparatide; parenteral
5.8
7.2
19
33
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
7.2
346
2586
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
3.7
7.2
22
60
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
3.7
7.2
22
60
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.5
7.2
207
1402
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
7.2
823
6980
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.3
7.2
50
217
R03AC03
ATC
terbutaline; inhalant
1.5
7.2
254
1795
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.2
7.2
55
249
L01EJ01
ATC
ruxolitinib; oral
20.1
7.1
10
5
J94.8
ICD-10 Finland
Other specified pleural conditions
2.8
7.1
35
128
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
2.6
7.1
40
157
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
7.1
612
5000
L26
ICD-10 Finland
Exfoliative dermatitis
12.1
7.1
12
10
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.1
7.0
61
290
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
3.0
7.0
29
96
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
2.5
7.0
43
176
S01GX01
ATC
cromoglicic acid; ophthalmic
1.4
7.0
358
2702
PE1AT
NOMESCO Finland
Femoral artery PTA
2.9
7.0
31
107
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
1.7
7.0
131
800
L01BB02
ATC
mercaptopurine; oral
3.2
7.0
27
86
3AC01, ,
NOMESCO Finland
3.2
7.0
26
81
N05AB03
ATC
perphenazine; systemic, rectal
2.1
7.0
66
325
N03AX12
ATC
[U] gabapentin; oral
1.4
6.9
305
2243
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
2.5
6.9
41
165
C01CA24
ATC
epinephrine; parenteral
1.7
6.9
117
695
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
6.9
189
1265
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
7.5
6.9
15
20
TK800
NOMESCO Finland
Hemodialysis
2.4
6.9
45
190
N05BA06
ATC
lorazepam; systemic, sublingual
1.8
6.9
100
569
N06AX21
ATC
duloxetine; oral
1.5
6.9
224
1557
D11AH01
ATC
tacrolimus; topical
3.6
6.9
22
62
A10BA02
ATC
metformin; oral
1.3
6.9
553
4472
D02AE01
ATC
carbamide; topical
1.7
6.8
119
713
K59.1
ICD-10 Finland
Functional diarrhoea
1.7
6.8
112
660
ED1AA
NOMESCO Finland
Mandibular X-ray examination
4.1
6.8
18
44
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
3.0
6.8
29
98
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.4
6.8
45
191
A41.8
ICD-10 Finland
Other specified sepsis
2.5
6.8
42
173
SPAT1281
SPAT
Other administrative function
1.6
6.8
148
941
324
Kela drug reimbursment
Dasatinib
40.2
6.8
8
*
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
3.6
6.7
21
58
174
Kela drug reimbursment
Ruxolitinib
16.7
6.7
10
6
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.8
6.7
103
595
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
1.8
6.7
105
610
K92.1
ICD-10 Finland
Melaena
1.8
6.7
105
610
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
6.7
281
2049
R06AX27
ATC
desloratadine; oral
1.3
6.7
524
4218
M10.9
ICD-10 Finland
Gout, unspecified
1.6
6.7
138
865
I42.3
ICD-10 Finland
Endomyocardial (eosinophilic) disease
22.6
6.7
9
*
J96.0
ICD-10 Finland
Acute respiratory failure
2.9
6.6
30
105
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.0
6.6
68
345
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
6.6
1222
10937
F20.9
ICD-10 Finland
Schizophrenia, unspecified
2.4
6.6
43
181
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
6.6
482
3840
H53.1
ICD-10 Finland
Subjective visual disturbances
1.7
6.6
129
797
D11
ICPC
Diarrhoea
1.5
6.6
218
1519
R06AE09
ATC
levocetirizine; oral
1.4
6.6
257
1849
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.3
6.6
46
200
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
3.6
6.6
21
59
R04.2
ICD-10 Finland
Haemoptysis
2.0
6.6
69
353
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.6
6.6
149
956
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
6.6
149
956
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.6
6.6
155
1004
C08CA01
ATC
amlodipine; oral
1.3
6.6
746
6303
J12.8
ICD-10 Finland
Other viral pneumonia
3.5
6.6
22
64
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
6.6
129
799
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.7
6.5
126
776
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
3.8
6.5
19
50
B74
ICPC
Malignant neoplasm blood other
10.0
6.5
12
12
9109
FHL
Other measure in this category
10.0
6.5
12
12
C09AA05
ATC
ramipril; oral
1.3
6.5
472
3757
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.8
6.5
94
534
K11.2
ICD-10 Finland
Sialoadenitis
2.0
6.5
63
313
L88
ICPC
Rheumatoid/seropositive arthritis
1.9
6.5
78
418
TQW80
NOMESCO Finland
Local dermatologic skincare
2.2
6.5
53
247
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.0
6.4
66
335
UDM02
NOMESCO Finland
Sinoscopy
2.3
6.4
45
196
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
2.9
6.4
28
96
C91
ICD-10 Finland
Lymphoid leukaemia
70.1
6.4
7
*
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
70.1
6.4
7
*
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
3.2
6.4
24
75
OAB50, ,
SPAT
1.6
6.4
162
1066
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
14.3
6.4
10
7
N05AH03
ATC
olanzapine; systemic
1.7
6.4
118
719
R5140
NOMESCO Finland
Monitoring the use of the aid
1.5
6.4
209
1454
B02.9
ICD-10 Finland
Zoster without complication
1.6
6.4
133
836
XKD00
NOMESCO Finland
Uroflowmetry
1.4
6.4
293
2172
M79.6
ICD-10 Finland
Pain in limb
1.3
6.4
856
7375
TKC20
NOMESCO Finland
Catheterisation of bladder
1.6
6.4
128
798
D86.0
ICD-10 Finland
Sarcoidosis of lung
3.0
6.3
26
86
R01AD05
ATC
budesonide; nasal
1.6
6.3
138
877
B01AB04
ATC
dalteparin; parenteral
1.8
6.3
96
554
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
5.2
6.3
18
35
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.0
6.3
62
310
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
2.6
6.3
34
131
K29.7
ICD-10 Finland
Gastritis, unspecified
2.0
6.3
66
338
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.3
6.3
23
71
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.5
6.3
37
149
C01DA14
ATC
isosorbide mononitrate; oral
1.4
6.3
284
2099
R01AD58
ATC
fluticasone, combinations; nasal
1.3
6.3
445
3530
L04AA10
ATC
[U] sirolimus
18.1
6.3
9
5
2889X
ICD-9 Finland
Diseases of white blood cells, Unspecified disease of white blood cells
+∞
6.3
6
*
C92.7
ICD-10 Finland
Other myeloid leukaemia
+∞
6.3
6
*
D73.0
ICD-10 Finland
Hyposplenism
+∞
6.3
6
*
D70
ICD-10 Finland
Agranulocytosis
+∞
6.3
6
*
C91.5
ICD-10 Finland
Adult T-cell lymphoma/leukaemia [HTLV-1-associated]
+∞
6.3
6
*
C91.4
ICD-10 Finland
Hairy-cell leukaemia
26.7
6.2
8
*
L01XX35
ATC
anagrelide; oral
26.7
6.2
8
*
A02BA02
ATC
ranitidine; systemic
1.4
6.2
346
2647
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
3.7
6.2
19
52
N03AX18
ATC
lacosamide; systemic
3.7
6.2
19
52
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.3
6.2
433
3427
R60.9
ICD-10 Finland
Oedema, unspecified
1.7
6.2
109
656
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.8
6.2
85
476
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.2
6.2
1066
9437
Z01.9
ICD-10 Finland
Special examination, unspecified
1.7
6.2
117
718
UKC02
NOMESCO Finland
Cystoscopy
1.4
6.2
302
2262
L03
ICD-10 Finland
Cellulitis
3.2
6.1
23
72
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.0
6.1
66
341
H03AA01
ATC
levothyroxine sodium; systemic
1.3
6.1
419
3305
X57
ICD-10 Finland
Unspecified privation
2.2
6.1
46
207
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.8
6.1
90
515
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.8
6.1
89
508
N03AG01
ATC
valproic acid; systemic, rectal
1.7
6.1
110
667
J01DA06
ATC
[U] cefuroxime
1.4
6.1
254
1851
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
12.5
6.1
10
8
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.3
6.1
44
195
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.7
6.1
96
561
A06AC51
ATC
ispaghula, combinations; oral
1.8
6.1
87
494
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
2.9
6.0
27
94
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.0
6.0
65
336
Z22.3
ICD-10 Finland
Carrier of other specified bacterial diseases
10.0
6.0
11
11
M81.4
ICD-10 Finland
Drug-induced osteoporosis
5.2
6.0
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
870
2368
5.40
311.10
5.1
2.6
1.79
1.81
%
0.16
818
2127
405
294
16.62
307.65
1.9
1.6
—
—
—
0
0
1014
2340
7.13
307.65
8.8
3.9
248.97
245.04
u/l
0.21
980
2229
715
1550
6.33
307.65
3.9
2.9
9.77
10.80
g/l
5.75
660
1434
722
1823
5.39
278.51
5.4
2.6
71.90
69.27
e9/l
0.96
543
1333
583
1222
6.11
276.82
2.1
1.9
1.33
1.41
g/l
0.25
529
1133
1782
9531
5.40
246.91
16.8
6.4
33.00
27.44
%
30.11
1735
9062
1739
9358
4.95
232.60
15.6
6.3
51.41
57.53
%
41.62
1703
8959
1788
10167
4.89
212.89
15.3
6.2
0.06
0.04
e9/l
1.40
1643
8699
1785
10148
4.87
212.31
15.3
6.2
0.71
0.58
e9/l
9.60
1637
8682
1808
10478
4.90
206.76
17.0
6.4
0.30
0.19
e9/l
17.11
1679
9108
1796
10361
4.83
206.59
15.5
6.3
4.26
1.92
e9/l
17.02
1683
9100
250
290
9.59
201.42
6.4
3.2
0.91
1.31
%
0.92
234
264
191
157
13.22
194.88
3.2
2.3
1688.43
1178.92
e6/l
0.46
164
143
1825
11351
4.41
171.54
21.4
9.2
4.46
4.13
e9/l
3.62
1711
9828
381
860
5.14
161.36
1.6
1.5
2.16
22.00
iu/ml
—
9
22
564
1737
4.01
159.79
2.4
2.9
66.14
66.40
g/l
0.30
526
1608
252
400
6.98
154.51
6.8
5.3
319.09
712.73
iu/ml
0.48
32
48
270
462
6.51
153.94
2.2
1.6
—
—
—
0
0
145
115
13.42
150.73
2.4
2.3
—
—
—
0
0
220
320
7.52
146.00
3.2
2.9
890.47
1838.00
u/ml
0.39
15
23
462
1312
4.18
145.46
2.5
1.3
474.97
214.74
u/ml
2.34
431
1227
140
116
12.81
141.62
3.3
2.5
810.25
520.17
e6/l
0.47
106
99
137
119
12.20
134.47
3.5
2.5
206.89
207.37
e6/l
0.01
112
108
1640
10450
3.18
127.13
10.8
6.4
10.65
11.64
umol/l
3.58
1595
9993
863
3983
2.91
121.89
1.9
1.5
2.17
2.47
g/l
5.56
638
2471
197
315
6.77
119.33
1.4
1.2
47.98
46.01
u/l
0.04
182
268
708
2975
3.03
118.14
3.5
2.7
22.64
22.61
%
0.02
663
2778
196
323
6.56
115.24
1.8
1.7
1.20
0.83
g/l
1.75
142
255
119
106
11.81
114.76
2.5
1.8
—
—
—
0
0
119
106
11.81
114.76
2.5
1.8
—
—
—
0
0
353
973
4.12
114.19
2.3
1.8
1.35
1.53
g/l
3.21
301
846
729
3229
2.87
109.12
3.4
2.7
2.31
2.30
g/l
0.10
686
2991
308
793
4.35
108.95
2.2
2.5
2.98
2.94
g/l
0.33
284
725
199
354
6.08
108.26
1.5
1.4
152.61
146.74
au/ml
0.24
61
102
291
730
4.44
106.39
2.2
2.6
0.65
1.24
g/l
1.64
255
634
317
851
4.18
105.94
2.2
2.5
3.54
3.76
g/l
1.43
292
783
317
852
4.17
105.77
2.2
2.4
7.09
7.40
g/l
2.33
293
783
317
852
4.17
105.77
2.2
2.4
4.12
4.20
g/l
0.74
293
784
1410
8763
2.67
105.40
24.7
11.4
0.00
0.00
e9/l
1.34
1224
7130
754
3472
2.77
103.98
3.5
2.7
12.54
12.95
umol/l
0.82
711
3242
263
623
4.65
103.31
2.1
2.4
0.12
0.02
g/l
0.44
234
564
141
189
7.90
99.98
7.1
2.9
44.23
57.21
%
6.02
123
170
113
115
10.30
99.40
1.5
1.8
8.83
8.72
ug/l
0.02
99
102
974
5199
2.56
98.25
4.9
2.8
346.78
344.94
umol/l
0.21
903
4598
252
603
4.59
97.59
2.1
2.5
0.01
0.00
g/l
0.50
221
532
1408
8936
2.57
97.55
7.4
5.2
35.01
35.60
g/l
3.30
1329
8403
281
734
4.24
97.11
2.2
2.5
10.13
10.36
g/l
0.27
255
661
233
528
4.81
96.47
1.9
2.1
12.18
11.95
mg/l
0.13
216
492
56
12
47.85
95.66
1.3
1.1
—
—
—
0
0
638
2810
2.78
94.58
9.5
6.0
1.05
1.04
mmol/l
0.45
609
2617
1516
10066
2.59
93.72
12.4
7.5
1.21
1.21
mmol/l
0.18
1277
8719
251
629
4.37
91.45
2.4
3.5
2.73
3.38
ratio
0.17
147
364
189
375
5.42
91.21
1.3
1.3
243.00
245.55
u/ml
0.04
126
228
235
564
4.54
90.48
2.2
2.5
0.00
0.00
g/l
-0.00
221
531
266
702
4.17
90.45
2.6
3.7
46.38
56.74
mg/l
0.52
213
602
1400
9047
2.48
90.29
11.4
6.9
1.21
1.21
mmol/l
0.87
1330
8378
266
703
4.16
90.27
2.5
3.7
37.56
84.61
mg/l
1.33
212
605
133
193
7.27
87.83
1.5
1.4
0.55
0.39
g/l
0.57
88
142
133
193
7.27
87.83
1.5
1.4
2.82
2.86
g/l
0.05
89
142
133
193
7.27
87.83
1.5
1.4
6.66
6.75
g/l
0.05
89
143
51
12
43.48
85.21
1.1
1.1
—
—
—
0
0
67
36
19.16
85.02
1.2
1.6
—
—
—
0
0
704
3420
2.55
84.15
5.9
3.5
0.81
0.82
mmol/l
1.75
674
3236
474
1913
2.88
81.65
2.8
2.3
339.28
375.97
nmol/l
3.95
456
1778
47
12
39.99
76.91
10.2
7.1
—
—
—
0
0
174
373
4.98
76.64
1.5
1.2
169.33
400.00
titre
0.81
15
30
1922
14995
3.09
75.67
16.2
8.1
82.47
79.10
u/l
1.99
1885
14264
280
871
3.53
74.62
2.1
1.9
41.41
38.63
u/l
1.07
254
775
236
673
3.80
71.51
2.1
1.7
—
—
—
0
0
202
525
4.13
69.65
2.4
1.5
—
—
—
0
0
217
598
3.91
68.98
2.0
1.7
0.22
0.24
g/l
1.01
204
569
159
347
4.86
68.45
2.8
1.6
—
—
—
0
0
220
618
3.84
68.03
2.0
1.7
1.15
1.19
g/l
0.94
210
588
135
259
5.48
67.35
1.9
1.6
—
—
—
0
0
201
539
4.00
66.33
2.7
1.5
—
—
—
0
0
1841
14378
2.64
65.91
7.8
4.4
14.19
12.16
mm/h
5.87
1775
13439
113
193
6.12
63.68
1.0
1.0
—
—
—
0
0
658
3457
2.28
63.00
2.8
1.9
—
—
—
0
0
153
348
4.65
62.57
1.6
1.3
19.58
4.40
u/ml
—
5
5
938
5686
2.12
62.52
4.4
3.3
0.45
0.42
e6/l
0.13
752
4190
1038
6594
2.08
60.46
4.5
3.5
68.90
77.83
e6/l
0.08
851
5055
897
5430
2.09
59.17
3.1
2.4
3.02
2.80
mg/l
1.78
793
4702
243
817
3.22
56.64
2.1
1.9
10.29
7.29
iu/ml
0.66
48
193
202
606
3.57
56.44
3.4
2.7
3.54
3.65
g/l
0.45
193
573
784
4579
2.10
56.28
3.5
2.7
6.05
5.46
e6/l
0.23
717
4177
1329
9387
2.04
56.13
4.7
3.1
189.76
123.94
ug/l
2.99
1250
8766
848
5119
2.06
55.51
6.7
4.3
87.57
88.61
%
0.59
831
5021
521
2600
2.31
55.41
2.4
1.8
—
—
—
0
0
82
118
7.18
54.40
2.5
2.7
35.60
42.00
%
1.00
33
60
475
2304
2.35
53.80
4.8
2.8
7.07
8.12
umol/l
0.50
417
2035
109
211
5.38
53.75
2.3
2.5
15.06
47.27
iu/ml
1.79
19
27
1118
7529
1.98
52.94
5.5
4.1
66.84
103.08
e6/l
1.29
889
5316
584
3127
2.18
51.86
3.6
2.2
30.45
29.67
s
1.60
576
3042
1549
11737
2.06
51.60
7.9
5.3
6.68
6.72
mmol/l
0.34
1495
11146
1291
9210
1.96
50.78
16.4
15.9
1.24
1.27
inr
1.02
1145
7673
490
2471
2.26
50.29
2.4
1.8
—
—
—
0
0
1003
6669
1.92
47.72
4.8
3.3
40.06
33.63
u/l
1.19
957
6303
72
104
7.12
47.58
3.3
2.5
1431.96
1049.43
u/ml
0.56
72
104
151
421
3.78
46.90
1.8
1.4
—
—
—
0
0
117
270
4.52
46.88
1.9
1.5
—
—
—
0
0
420
2055
2.29
45.94
4.7
3.4
—
—
—
0
0
87
161
5.58
45.03
1.7
1.3
3.90
1.13
u/ml
0.73
44
90
202
699
3.08
44.55
2.6
2.7
—
—
—
0
0
154
451
3.59
44.46
1.8
1.4
—
—
—
0
0
79
139
5.86
43.12
1.4
1.2
91.79
76.13
—
8
8
1014
6926
1.85
42.95
4.0
3.4
2.34
2.35
mmol/l
1.76
945
6302
394
1933
2.26
42.56
10.9
7.5
10.66
9.99
mmol/l
0.98
377
1863
71
114
6.40
42.48
1.3
1.2
—
—
—
0
0
911
6081
1.84
41.01
3.7
3.2
1895.57
1375.60
ng/l
1.42
802
5243
711
4392
1.91
40.81
2.4
1.8
1.24
1.23
mg/l
0.02
568
3399
318
1448
2.40
40.74
2.1
1.6
—
—
—
0
0
337
1588
2.32
39.87
5.5
3.7
1.21
1.23
mmol/l
2.63
300
1364
132
375
3.68
39.83
1.8
1.4
—
—
—
0
0
179
619
3.06
39.44
1.5
1.4
—
—
—
0
0
1221
9012
1.79
38.43
3.3
2.5
76.76
77.11
nmol/l
0.16
1132
8145
80
159
5.18
38.27
1.2
1.1
85.45
142.22
titre
0.56
11
27
43
6
72.87
38.03
1.3
1.3
—
—
—
0
0
135
407
3.47
37.22
5.7
4.6
2.40
2.58
mmol/l
0.25
93
269
912
6301
1.76
35.01
3.2
2.7
54.49
73.36
u/l
0.86
862
5857
78
164
4.89
34.97
1.9
1.6
—
—
—
0
0
898
6179
1.76
34.95
3.2
2.2
169.04
222.86
u/l
1.79
851
5856
77
161
4.92
34.75
1.9
1.5
—
—
—
0
0
176
651
2.85
34.29
6.2
3.9
1.59
1.56
mg/l
0.22
165
594
63
112
5.76
34.02
1.9
1.4
—
—
—
0
0
384
2028
2.08
33.79
2.6
2.3
0.21
0.21
g/l
0.50
354
1897
109
306
3.69
33.45
1.8
1.4
—
—
—
0
0
42
11
38.91
33.45
1.1
1.0
—
—
—
0
0
192
758
2.68
32.99
1.3
1.2
0.24
0.72
u/ml
—
10
51
1187
8923
1.71
32.89
2.5
2.2
95.71
94.80
pmol/l
0.28
718
4778
81
185
4.51
32.86
1.2
1.2
86.25
58.76
u/l
0.43
76
167
854
5870
1.74
32.82
2.1
1.7
20.16
20.22
nmol/l
0.04
763
4954
62
116
5.47
31.71
1.9
1.4
—
—
—
0
0
555
3410
1.84
30.96
2.1
1.7
1197.75
1163.70
nmol/l
0.37
445
2595
65
131
5.08
30.62
1.9
1.4
—
—
—
0
0
123
396
3.23
30.51
1.5
1.3
—
—
—
0
0
123
396
3.23
30.51
1.5
1.3
—
—
—
0
0
1567
12895
1.73
29.38
6.2
4.7
213.09
1558.12
e6/l
2.33
35
179
119
386
3.20
29.15
1.8
1.4
—
—
—
0
0
1023
7559
1.66
28.87
5.3
3.9
35.05
68.81
ng/l
1.74
773
5389
165
649
2.67
28.50
1.6
1.5
0.21
11.29
iu/ml
0.49
20
107
605
3901
1.76
28.30
4.9
4.0
394.32
447.30
ng/l
0.19
488
3072
75
185
4.16
27.57
3.5
1.6
—
—
—
0
0
151
580
2.72
27.31
1.3
1.2
29.37
36.54
u/ml
—
6
27
275
1381
2.13
27.29
6.5
4.2
5.19
5.14
kpa
0.41
261
1338
144
547
2.75
26.61
1.4
1.2
3.45
4.00
u/ml
0.09
19
48
146
561
2.72
26.39
1.9
1.7
—
—
—
0
0
521
3283
1.77
26.10
4.0
3.2
2.79
2.35
e6/l
0.39
291
1609
79
211
3.85
26.06
3.4
1.5
—
—
—
0
0
30
31
9.80
25.91
1.6
1.4
—
—
—
0
0
49
89
5.61
25.88
5.3
3.3
0.90
1.15
%
0.38
49
89
669
4532
1.68
25.70
1.4
1.3
1.23
1.59
u/ml
0.41
183
1233
565
3663
1.73
25.51
1.4
1.3
35.12
31.72
iu/ml
0.27
178
1128
1299
10398
1.60
24.95
5.0
3.9
0.00
0.00
estimate
0.50
387
2206
2063
18797
2.37
24.91
34.6
16.3
22.90
24.69
mg/l
1.87
1879
15543
141
550
2.67
24.73
1.4
1.2
6.01
8.75
u/ml
0.36
27
79
1310
10526
1.60
24.60
5.0
3.9
6.77
2.97
estimate
0.34
392
2242
42
69
6.19
24.58
1.2
1.1
—
—
—
0
0
1314
10582
1.59
24.30
5.0
3.9
0.01
0.01
estimate
0.13
361
2101
1536
12880
1.62
23.61
4.4
3.4
60.40
48.63
u/l
3.79
1455
12134
143
579
2.57
23.26
1.2
1.2
101.76
92.68
titre
0.14
17
56
1794
15716
1.74
22.65
42.6
20.1
14.23
13.64
%
42.27
1781
15505
120
453
2.74
22.44
1.4
1.2
3.17
5.10
u/ml
—
7
28
47
95
5.03
22.10
4.4
3.7
—
—
—
0
0
246
1280
2.04
22.03
2.1
1.7
—
—
—
0
0
144
606
2.47
21.59
1.6
1.3
—
—
—
0
0
230
1181
2.06
21.34
7.1
4.1
2.34
1.76
mmol/l
1.51
173
877
537
3587
1.66
21.10
3.9
3.0
0.71
1.17
e6/l
2.54
315
1916
70
202
3.55
20.66
3.7
4.1
—
—
—
0
0
132
545
2.51
20.61
5.3
3.3
2.11
1.88
index
0.24
80
283
516
3443
1.65
20.25
1.4
1.3
8.85
12.13
u/ml
0.77
164
1317
177
838
2.21
20.24
2.7
1.8
1.68
1.80
ug/l
0.07
159
745
113
437
2.67
20.17
1.3
1.2
50.91
50.64
u/ml
0.01
15
42
59
155
3.88
19.96
1.1
1.1
—
—
—
0
0
59
155
3.88
19.96
1.1
1.1
—
—
—
0
0
58
151
3.92
19.87
1.1
1.1
—
—
—
0
0
400
2509
1.72
19.77
2.6
2.5
157.28
128.86
ug/g
0.58
327
2026
86
290
3.04
19.76
1.1
1.1
1.63
1.50
g/l
1.53
80
265
67
194
3.53
19.69
1.5
1.2
—
—
—
0
0
57
148
3.93
19.60
1.2
1.1
—
—
—
0
0
760
5592
1.55
19.59
4.6
3.3
0.01
0.17
estimate
0.58
326
1739
60
162
3.78
19.53
1.2
1.1
—
—
—
0
0
330
1967
1.80
19.46
2.9
2.5
33.92
64.79
u/l
0.67
288
1657
119
488
2.52
18.86
3.3
2.3
123.12
130.01
g/l
1.88
93
395
53
135
4.00
18.72
1.3
1.2
—
—
—
0
0
53
136
3.97
18.53
1.3
1.2
—
—
—
0
0
34
60
5.74
18.53
1.6
1.5
—
—
—
0
0
1152
9331
1.49
18.35
4.5
2.8
—
—
estimate
—
0
0
63
184
3.49
18.29
1.1
1.2
—
—
—
0
0
340
2085
1.74
18.10
7.5
3.9
1.45
1.73
mmol/l
0.67
302
1807
1690
14890
1.56
17.42
5.1
4.4
14.88
14.79
pmol/l
0.70
1568
13670
42
95
4.49
17.31
4.5
1.5
—
—
—
0
0
42
95
4.49
17.31
4.5
1.5
—
—
—
0
0
42
95
4.49
17.31
4.5
1.5
—
—
—
0
0
42
95
4.49
17.31
4.5
1.5
—
—
—
0
0
86
313
2.82
17.26
1.3
1.2
3.81
3.77
u/ml
0.01
32
114
45
108
4.23
17.21
1.3
1.1
—
—
—
0
0
36
72
5.07
17.16
5.0
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
144
675
2.21
16.86
7.7
3.1
0.33
0.36
iu/ml
0.49
87
364
342
2141
1.71
16.82
7.5
3.9
5.90
5.82
kpa
0.74
330
2090
58
170
3.48
16.76
1.0
1.0
—
—
—
0
0
271
1592
1.80
16.65
5.8
4.1
97.60
91.57
ng/l
0.47
239
1390
83
303
2.81
16.58
1.3
1.2
4.21
5.32
u/ml
0.33
43
134
35
71
4.99
16.42
5.1
1.5
—
—
—
0
0
35
71
4.99
16.42
5.1
1.5
—
—
—
0
0
564
4019
1.54
16.25
3.1
3.0
2.45
2.45
mmol/l
0.34
501
3616
74
259
2.92
15.97
1.7
1.6
30.75
29.65
ng/l
0.03
74
259
40
93
4.36
15.95
1.2
1.5
—
1631885.57
iu/ml
—
0
7
35
74
4.79
15.66
1.3
1.3
—
—
—
0
0
219
1227
1.87
15.65
1.3
1.3
26.51
51.76
au/ml
2.06
11
93
2053
19154
1.95
15.59
35.5
19.5
139.34
139.65
mmol/l
6.42
2028
18800
71
247
2.94
15.50
2.1
2.5
1.48
1.35
g/24h
0.12
44
150
2054
19187
1.94
15.23
36.8
19.6
3.98
3.98
mmol/l
0.25
2025
18801
78
289
2.76
15.17
1.6
1.5
35.44
32.29
g/l
1.13
66
258
582
4240
1.50
14.92
1.9
1.8
44958431.36
28571860.07
pmol/l
0.20
476
3535
41
103
4.04
14.80
1.1
1.1
—
—
—
0
0
34
74
4.65
14.71
1.9
1.3
—
—
—
0
0
34
74
4.65
14.71
1.9
1.3
—
—
—
0
0
231
1344
1.80
14.60
2.5
2.5
23.95
20.93
au/ml
0.15
22
134
149
752
2.05
14.43
2.9
2.2
552.92
473.06
ug/l
0.12
142
712
51
154
3.37
14.12
2.1
1.5
25.43
20.47
u/ml
—
7
30
29
57
5.14
14.11
1.4
1.3
—
—
—
0
0
221
1287
1.80
13.91
11.8
11.0
24.14
24.25
mmol/l
0.18
213
1262
41
108
3.85
13.88
1.8
1.3
—
—
—
0
0
41
108
3.85
13.88
1.8
1.3
—
—
—
0
0
258
1576
1.72
13.75
3.9
3.1
261.21
215.47
ng/l
0.77
234
1450
207
1187
1.82
13.71
3.0
3.6
4.45
4.51
pmol/l
0.16
179
1059
53
168
3.21
13.59
3.8
1.4
—
—
—
0
0
53
168
3.21
13.59
3.8
1.4
—
—
—
0
0
53
168
3.21
13.59
3.8
1.4
—
—
—
0
0
751
5842
1.43
13.45
5.2
4.0
0.00
0.00
estimate
1.54
359
2043
362
2443
1.58
12.98
9.8
8.6
5.12
5.09
kpa
0.19
344
2357
362
2443
1.58
12.98
9.8
8.6
11.63
12.24
kpa
1.57
344
2359
880
7084
1.40
12.81
4.0
3.5
7.20
7.61
mmol/l
2.01
733
6031
40
110
3.68
12.76
1.5
1.5
8.48
7.44
u/l
0.12
31
92
117
572
2.10
12.35
1.6
1.3
—
—
—
0
0
62
228
2.77
12.28
1.5
1.4
190660.87
99774.84
e6/l
0.32
38
125
355
2423
1.55
12.05
9.9
8.6
0.90
0.88
mmol/l
0.03
292
1994
1940
18041
1.60
11.89
30.8
15.9
79.79
80.57
ml/min/173m2
0.79
1837
16690
70
281
2.54
11.69
1.3
1.3
0.17
0.38
nmol/l
—
10
19
836
6765
1.38
11.43
5.0
4.3
12.32
8.78
mg/mmol
1.22
542
4283
66
261
2.58
11.37
1.3
1.1
—
—
—
0
0
119
613
1.99
10.93
1.5
1.5
290.82
275.38
ug/g
0.31
72
370
182
1078
1.75
10.79
1.5
1.5
—
—
—
0
0
98
472
2.13
10.78
2.6
2.8
35.44
33.57
umol/l
0.24
92
426
66
268
2.51
10.78
1.5
1.4
3010.94
5218.58
e6/l
0.28
48
182
242
1555
1.62
10.57
1.9
1.5
—
—
—
0
0
17
12
14.26
10.48
2.1
1.4
1.21
3.63
mg/l
—
7
6
37
112
3.34
10.27
2.2
1.5
5.82
7.66
u/l
0.60
31
95
1329
11685
1.34
10.05
3.4
3.0
—
—
—
0
0
16
11
14.64
9.99
2.1
1.4
2.24
0.53
mg/l
—
9
5
16
11
14.64
9.99
2.1
1.4
5.80
1.73
mg/l
—
10
6
16
11
14.64
9.99
2.1
1.4
0.46
2.96
mg/l
—
7
5
16
11
14.64
9.99
2.1
1.4
0.40
7.96
mg/l
—
8
5
66
280
2.40
9.84
1.1
1.1
114.31
115.76
%
0.14
61
261
59
238
2.52
9.80
1.3
1.2
0.18
0.26
nmol/l
0.52
49
189
267
1791
1.56
9.70
6.9
3.3
4.48
4.54
kpa
0.21
255
1746
36
112
3.25
9.59
8.1
3.6
0.72
0.87
index
0.82
36
112
193
1201
1.66
9.56
12.2
11.5
15.35
15.98
%
2.32
183
1160
31
88
3.56
9.50
1.3
1.1
—
—
—
0
0
936
7874
1.33
9.35
5.0
3.8
0.00
0.08
estimate
0.89
340
1829
59
244
2.46
9.32
1.4
1.4
400.02
320.23
pmol/l
0.62
48
208
312
2186
1.50
9.25
10.7
9.0
94.78
95.59
%
1.21
297
2122
34
105
3.27
9.17
3.3
7.6
—
58.37
u/ml
—
0
27
631
5021
1.36
9.13
4.6
2.4
—
—
—
0
0
14
9
15.65
9.03
3.2
3.3
—
—
—
0
0
2069
19760
1.69
8.87
23.2
12.1
26.43
25.97
u/l
0.55
2045
19218
80
385
2.12
8.87
1.3
1.1
0.80
2.82
u/ml
2.72
50
223
54
221
2.48
8.74
2.0
1.3
—
—
—
0
0
54
221
2.48
8.74
2.0
1.3
—
—
—
0
0
1880
17605
1.44
8.68
6.4
5.4
1.90
1.92
mu/l
0.33
1756
16299
55
228
2.45
8.66
1.7
1.7
54.27
59.81
%
0.41
36
143
54
222
2.47
8.66
2.0
1.3
—
—
—
0
0
72
339
2.16
8.46
1.8
1.9
4.48
4.89
mmol/24h
0.58
67
295
55
231
2.42
8.43
1.5
1.5
6.21
6.46
mmol/l
0.26
50
216
14
11
12.80
8.37
1.2
1.1
1.65
1.09
iu/ml
—
8
5
54
227
2.41
8.27
2.0
1.3
—
—
—
0
0
22
54
4.10
8.26
1.4
1.2
—
—
—
0
0
46
181
2.57
8.09
3.2
2.5
—
—
—
0
0
288
2039
1.47
8.07
11.0
9.6
116.92
121.02
g/l
2.50
278
1998
54
230
2.38
8.04
2.0
1.3
—
—
—
0
0
130
764
1.75
7.96
3.4
1.9
—
—
—
0
0
19
43
4.45
7.90
1.5
1.2
—
—
—
0
0
25
72
3.50
7.54
2.5
2.4
0.61
0.61
mmol/l
0.15
25
72
2074
19919
1.62
7.43
40.4
21.2
83.17
78.25
umol/l
5.48
2059
19707
21
54
3.92
7.43
1.3
1.3
74.84
29.81
ug/l
0.26
11
24
62
291
2.16
7.38
1.2
1.1
—
—
—
0
0
52
230
2.29
7.15
2.1
1.3
—
—
—
0
0
10
5
20.08
7.13
1.0
1.0
—
—
—
0
0
138
854
1.66
7.02
2.0
1.6
0.30
0.32
mg/l
0.20
66
404
53
240
2.24
6.91
1.6
1.3
271.70
278.26
mosm/kgh2o
1.31
44
175
117
700
1.71
6.76
2.1
1.8
—
—
—
0
0
15
21
7.18
6.70
2.2
2.0
—
—
—
0
0
195
1324
1.52
6.70
1.3
1.2
62.81
140.97
u/ml
3.88
65
504
99
567
1.78
6.67
1.7
1.4
9.87
9.54
u/l
0.07
75
450
38
151
2.54
6.61
1.7
2.3
642.11
641.05
ml
0.01
27
95
39
157
2.51
6.61
1.2
1.1
109.41
107.96
pmol/l
0.06
39
157
17
30
5.70
6.45
4.9
2.0
3.76
2.82
%
0.18
17
30
81
442
1.86
6.39
1.8
1.6
—
—
—
0
0
44
191
2.33
6.35
7.6
3.4
12.08
11.53
index
0.20
36
112
36
143
2.54
6.28
1.1
1.1
—
—
—
0
0
62
312
2.02
6.21
1.2
1.1
2.13
2.09
u/ml
0.01
35
166
23
72
3.22
6.15
2.2
2.4
59.28
52.64
ug/l
0.20
23
72
54
259
2.11
6.14
1.8
1.9
35.69
21.18
ug/l
0.74
54
254
21
62
3.41
6.14
1.6
1.7
74.53
84.52
nmol/24h
0.31
21
62
40
172
2.35
5.92
1.7
1.5
30.18
30.43
%
0.01
23
104
45
204
2.23
5.90
1.5
1.6
—
—
—
0
0
37
155
2.41
5.80
1.2
1.2
38.47
40.26
mg/l
0.10
28
128
35
143
2.47
5.79
2.3
1.7
—
—
—
0
0
47
219
2.17
5.77
8.7
6.1
6.94
7.32
mmol/l
0.35
38
183
29
108
2.71
5.76
1.9
1.4
22.28
22.89
umol/l
0.03
29
97
52
255
2.06
5.61
1.4
1.4
—
—
—
0
0
29
110
2.66
5.57
1.1
1.2
1.06
1.06
ratio
0.04
24
97
194
1373
1.45
5.45
13.9
11.2
0.61
0.64
%
0.41
189
1365
275
2077
1.37
5.33
3.1
4.3
43.29
16.91
ug/l
0.55
222
1692
61
324
1.91
5.28
1.2
1.1
2.51
5.17
u/ml
1.26
36
175
35
150
2.35
5.25
1.2
1.1
259.50
270.22
mg/l
0.13
30
131
30
120
2.52
5.21
1.2
1.1
—
—
—
0
0
82
480
1.74
5.20
2.8
1.6
575.69
656.61
e6/l
0.08
68
373
81
474
1.74
5.14
2.8
1.5
7.83
42.06
e6/l
1.18
63
352
14
27
5.21
5.08
1.1
1.0
—
—
—
0
0
118
765
1.57
5.04
9.2
4.5
24.82
24.78
mmol/l
0.05
110
720
26
99
2.65
4.98
1.8
1.8
—
—
—
0
0
24
88
2.75
4.94
1.2
1.1
64.82
231.58
ng/l
0.64
11
24
54
282
1.94
4.94
1.1
1.1
2.60
3.50
—
5
41
136
921
1.51
4.79
1.5
1.4
23.05
26.47
iu/l
0.65
111
776
81
486
1.69
4.73
2.3
1.4
3.66
3.75
mmol/l
0.32
74
460
23
85
2.72
4.68
2.0
1.6
40.26
39.95
g/l
0.08
23
85
91
565
1.64
4.67
1.3
1.3
—
—
—
0
0
35
159
2.22
4.63
1.2
1.3
2.16
2.01
mmol/l
0.25
30
148
139
1984
0.68
4.63
2.1
2.0
3.50
3.46
ratio
0.12
109
1548
1857
17736
1.29
4.59
7.6
6.5
39.92
39.39
mmol/mol
1.47
1738
16600
48
248
1.96
4.55
1.2
1.1
2.28
5.67
u/ml
1.22
20
111
42
207
2.05
4.53
1.1
1.1
—
—
—
0
0
220
1650
1.37
4.47
3.0
2.5
0.40
0.49
e6/l
0.36
214
1578
298
2339
1.32
4.47
2.2
1.8
1.59
1.49
%
1.43
263
2038
57
315
1.83
4.43
1.2
1.1
0.30
1.18
u/ml
1.65
30
147
83
511
1.65
4.42
1.3
1.2
—
—
—
0
0
23
88
2.63
4.40
1.6
2.7
86.38
120.04
umol/l
—
8
55
28
119
2.37
4.32
1.5
1.2
0.56
0.55
ratio
0.12
16
71
411
3380
1.27
4.29
1.7
1.6
—
—
—
0
0
14
41
3.43
4.18
2.2
2.2
14.24
17.15
umol/l
0.55
14
41
104
686
1.54
4.17
1.6
1.6
12.63
15.08
u/ml
0.23
18
154
34
160
2.14
4.16
1.4
1.3
—
—
—
0
0
50
271
1.86
4.15
1.2
1.1
6.66
3.50
u/ml
0.37
27
137
97
631
1.56
4.14
2.3
2.2
7728.43
5644.47
u/l
0.15
31
261
168
2262
0.72
4.01
9.1
7.0
—
—
—
0
0
37
183
2.04
3.99
1.3
1.2
—
—
titre
—
0
0
1888
18138
1.27
3.97
5.9
5.2
6.07
5.96
mmol/l
2.34
1752
16630
18
64
2.83
3.95
2.1
1.2
—
—
—
0
0
82
528
1.57
3.69
1.2
1.1
2.24
3.91
—
5
59
82
529
1.57
3.66
1.7
2.1
5.00
14.87
iu/l
0.44
35
217
42
228
1.86
3.51
2.2
2.1
15.20
8.16
umol/l
0.51
23
169
11
27
4.09
3.39
8.7
9.0
4.79
5.93
mmol/l
0.90
11
27
20
82
2.45
3.38
2.0
1.9
0.71
0.97
u/ml
—
6
19
81
533
1.54
3.35
1.4
1.1
—
—
—
0
0
2087
20399
1.38
3.30
51.2
24.8
253.87
249.41
e9/l
1.46
2058
20010
2087
20403
1.38
3.26
51.0
24.7
91.94
91.14
fl
9.65
2070
20193
2087
20406
1.38
3.22
52.3
25.3
39.43
40.27
%
10.99
2069
20184
2087
20406
1.38
3.22
51.1
24.8
4.35
4.48
e12/l
20.31
2051
19949
27
130
2.09
3.18
1.1
1.1
2.98
9.20
iu/ml
—
5
33
2087
20411
1.37
3.17
51.2
24.8
10.37
6.78
e9/l
31.37
2052
19947
2087
20412
1.37
3.16
51.5
25.0
130.43
134.89
g/l
29.87
2070
20203
73
477
1.55
3.13
2.5
2.3
155.94
115.99
ug/min
0.23
45
287
80
534
1.52
3.12
1.4
1.1
—
—
—
0
0
7
12
5.85
3.02
2.1
5.9
—
—
—
0
0
81
547
1.50
3.00
1.5
1.4
—
—
—
0
0
49
295
1.68
2.94
6.2
5.7
391.50
352.84
umol/l
1.02
42
259
171
1320
1.32
2.94
6.2
3.1
123.58
129.10
g/l
2.09
164
1284
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
24
115
2.10
2.88
1.4
1.1
—
—
—
0
0
885
8079
1.16
2.88
2.2
1.9
1.51
1.36
mmol/l
4.00
732
6825
108
1476
0.72
2.87
1.9
1.7
3.29
3.44
mmol/l
0.72
79
1043
77
522
1.49
2.82
1.7
1.6
12280.22
13666.63
e6/l
0.14
54
376
20
411
0.48
2.80
1.8
1.5
1.35
1.18
ratio
—
9
257
20
411
0.48
2.80
1.8
1.5
0.89
0.94
ratio
—
9
257
20
411
0.48
2.80
1.8
1.5
1.27
1.16
ratio
—
9
257
15
59
2.55
2.78
1.2
1.1
—
—
—
0
0
27
499
0.54
2.74
1.5
1.4
—
—
—
0
0
21
98
2.15
2.71
1.0
1.1
1952.95
1500.47
miu/ml
1.00
21
98
10
29
3.46
2.69
1.0
1.2
—
—
—
0
0
20
404
0.49
2.68
1.8
1.5
—
—
—
0
0
8
19
4.22
2.68
1.0
1.5
46.63
48.79
umol/l
—
8
19
147
1127
1.33
2.67
6.1
2.7
1.47
1.21
%
1.35
147
1120
10
30
3.34
2.60
1.2
1.1
—
—
—
0
0
5
7
7.15
2.55
1.6
5.6
—
—
—
0
0
6
11
5.47
2.54
3.3
3.7
—
—
—
0
0
13
50
2.61
2.53
1.1
1.1
—
—
—
0
0
8
21
3.82
2.46
1.3
1.1
—
—
—
0
0
93
674
1.40
2.44
1.6
1.7
322.74
302.23
mu/l
0.17
83
618
205
1670
1.25
2.35
2.8
2.3
11.98
12.94
nmol/l
0.96
176
1497
9
28
3.22
2.30
1.4
1.2
—
—
—
0
0
8
23
3.49
2.27
1.1
1.0
—
—
—
0
0
21
106
1.99
2.25
14.6
13.1
0.60
0.62
mmol/l
0.21
21
100
205
1680
1.24
2.24
2.4
2.4
10.80
7.33
ug/l
0.41
178
1507
15
66
2.28
2.24
1.3
1.5
75.33
90.75
%
—
9
36
15
67
2.25
2.17
1.3
1.1
77.44
93.33
%
—
9
36
7
19
3.69
2.15
1.1
1.1
0.03
3.14
u/ml
—
7
13
11
42
2.63
2.14
1.0
1.3
—
—
—
0
0
38
236
1.62
2.11
1.2
1.0
0.06
0.25
u/ml
1.06
17
88
101
763
1.34
2.09
2.8
3.4
1113.91
5356.81
u/ml
0.59
89
662
11
43
2.57
2.08
3.9
2.5
6.83
7.54
mmol/l
—
6
22
5
10
5.01
2.07
2.6
5.6
—
—
—
0
0
7
20
3.51
2.05
1.4
1.2
—
—
—
0
0
23
125
1.85
2.02
1.2
1.1
0.97
1.15
u/l
1.87
11
59
27
155
1.75
2.00
1.4
1.4
9.51
9.02
mmol/l
0.28
27
150
45
296
1.53
1.98
1.6
1.4
0.25
0.34
nmol/l
0.89
36
234
14
64
2.20
1.94
1.5
1.1
—
—
—
0
0
8
27
2.97
1.93
1.4
1.0
—
—
—
0
0
6
16
3.76
1.93
1.3
1.1
—
—
—
0
0
21
113
1.87
1.91
1.5
1.4
1.54
1.23
nmol/l
0.44
15
85
17
85
2.01
1.90
1.5
1.3
153.29
169.61
mmol/24h
0.59
17
85
61
432
1.42
1.88
2.3
3.6
20.92
930.72
u/ml
0.93
55
410
21
114
1.85
1.87
1.1
1.1
—
—
—
0
0
13
59
2.21
1.84
1.5
1.1
—
—
—
0
0
8
29
2.76
1.79
1.4
1.2
—
—
—
0
0
241
2059
1.19
1.78
2.0
2.1
—
—
—
0
0
13
60
2.17
1.77
1.5
1.1
—
—
—
0
0
5
13
3.85
1.71
1.2
1.1
0.02
0.55
u/ml
—
5
13
12
55
2.19
1.67
1.8
1.7
—
—
—
0
0
192
1617
1.21
1.67
3.7
2.7
57.91
65.84
ml/min/173m2
2.18
102
682
7
25
2.81
1.65
1.6
1.6
—
—
—
0
0
79
600
1.33
1.64
1.2
1.3
169.12
228.28
miu/ml
0.86
27
278
10
42
2.39
1.61
7.6
6.0
6.47
5.31
kpa
—
10
42
5
14
3.58
1.61
1.4
1.2
—
—
—
0
0
5
14
3.58
1.61
1.0
1.5
75.00
42.59
nmol/l
—
5
14
155
1283
1.22
1.61
7.4
7.0
24.84
24.37
mmol/l
0.74
146
1231
220
1885
1.19
1.59
2.0
2.0
—
—
—
0
0
23
136
1.70
1.59
1.1
1.1
18.50
17.17
u/ml
—
6
57
23
136
1.70
1.59
1.9
1.3
89.61
82.07
umol/l
0.54
23
136
21
121
1.74
1.58
2.0
1.7
109.67
107.15
ng/l
0.04
21
121
12
57
2.11
1.55
1.3
1.1
—
—
—
0
0
25
153
1.64
1.53
2.3
2.1
1.36
1.74
u/field
0.38
11
86
25
153
1.64
1.53
2.1
2.5
41.44
33.84
mg/l
0.23
16
112
58
425
1.37
1.53
3.3
3.5
0.73
0.82
nmol/l
1.10
47
351
5
15
3.34
1.52
1.0
1.3
—
—
—
0
0
140
1155
1.23
1.51
1.8
2.1
—
—
—
0
0
17
93
1.83
1.51
1.2
1.2
—
—
—
0
0
49
674
0.72
1.48
1.1
1.2
1.46
1.54
g/l
1.66
49
674
17
94
1.81
1.47
1.8
1.7
3.42
4.55
u/field
0.21
12
70
39
556
0.70
1.45
1.4
1.5
—
—
—
0
0
9
38
2.37
1.45
1.4
1.2
—
—
—
0
0
7
28
2.50
1.45
1.0
1.2
2.14
1.84
umol/24h
—
7
28
11
52
2.12
1.44
2.4
1.1
—
—
—
0
0
22
133
1.66
1.42
2.7
3.1
19.62
20.95
mu/l
0.09
22
128
45
622
0.72
1.41
1.0
1.1
0.64
0.64
ratio
—
9
78
30
197
1.53
1.40
1.5
1.3
36885.82
126570.08
e6/l
0.92
17
133
119
976
1.23
1.38
3.9
3.4
1.02
1.02
ratio
0.12
108
893
48
348
1.39
1.37
1.1
1.1
23.61
19.52
au/ml
—
7
82
5
17
2.95
1.36
5.6
5.2
—
—
—
0
0
15
82
1.83
1.35
1.3
1.1
—
—
—
0
0
0
37
0.00
1.34
0.0
1.2
—
1.18
—
0
37
116
953
1.23
1.33
1.6
2.0
—
—
—
0
0
15
83
1.81
1.31
1.1
1.0
—
—
—
0
0
6
24
2.50
1.30
3.3
1.9
—
—
—
0
0
14
76
1.85
1.29
2.4
2.7
1212.33
826.85
e6/l
—
9
60
77
608
1.28
1.26
2.2
1.9
35.70
40.51
nmol/l
1.01
71
587
1916
18815
1.13
1.26
6.3
5.8
2.55
2.67
mmol/l
7.07
1805
17495
1800
17614
1.12
1.25
4.8
4.3
1.41
1.29
mmol/l
8.20
1678
16201
8
37
2.17
1.21
1.4
1.2
—
—
—
0
0
6
26
2.31
1.18
1.3
1.2
—
—
—
0
0
54
411
1.32
1.17
6.8
7.5
105.68
105.10
mmol/l
0.39
47
372
54
702
0.76
1.17
1.1
1.2
0.90
0.89
g/l
0.15
54
702
37
266
1.40
1.14
1.6
1.6
46.37
56.74
ug/l
1.14
37
266
21
134
1.57
1.14
3.0
2.2
7.89
8.33
mmol/l
0.23
21
134
12
65
1.85
1.13
3.2
3.0
10.50
10.09
kpa
0.25
12
65
12
65
1.85
1.13
3.2
3.0
5.15
4.89
kpa
0.41
12
65
13
73
1.79
1.10
1.5
2.5
0.96
1.50
ug/l
0.83
13
68
8
41
1.95
1.08
3.6
3.2
2.38
5.17
ug/l
—
8
41
5
22
2.28
1.03
1.0
1.0
102.40
75.64
titre
—
5
22
109
921
1.19
1.00
5.7
5.2
1.83
1.57
%
1.11
101
873
18
115
1.57
0.99
2.7
1.9
—
—
—
0
0
5
23
2.18
0.98
5.8
1.1
—
—
—
0
0
0
32
0.00
0.95
0.0
2.1
—
—
—
0
0
0
32
0.00
0.95
0.0
2.2
—
—
—
0
0
1884
18546
1.10
0.94
5.6
5.2
4.41
4.58
mmol/l
10.57
1780
17323
11
62
1.78
0.94
1.7
1.1
—
—
—
0
0
51
400
1.28
0.93
5.9
3.6
28.75
27.13
mg/l
0.13
34
284
310
2835
1.11
0.93
1.6
1.5
—
—
—
0
0
8
42
1.91
0.88
1.3
1.1
—
—
—
0
0
19
127
1.50
0.88
1.7
1.4
—
—
—
0
0
51
404
1.27
0.88
1.5
1.5
96.20
210.51
pmol/l
1.71
51
395
62
758
0.81
0.86
1.7
1.6
931.18
1002.28
mu/l
0.28
54
633
1540
15739
0.93
0.86
43.4
21.1
329.89
332.31
g/l
19.42
1533
15649
13
203
0.64
0.84
1.3
1.2
—
—
—
0
0
58
471
1.24
0.82
2.3
1.9
183.55
206.90
pmol/l
1.10
51
447
106
913
1.17
0.82
1.4
1.3
—
—
—
0
0
28
206
1.36
0.81
1.1
1.3
—
—
—
0
0
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
213
2337
0.90
0.74
4.7
5.0
31.56
32.46
%
0.58
153
1554
7
38
1.84
0.73
1.4
1.1
—
—
—
0
0
11
68
1.62
0.71
1.3
1.3
180.20
116.94
nmol/l
—
5
52
5
27
1.85
0.68
6.6
7.3
10.86
10.79
%
—
5
27
9
59
1.53
0.68
1.9
1.1
—
—
—
0
0
1868
18444
1.08
0.67
5.6
5.0
1.36
1.45
mmol/l
16.04
1755
17106
13
88
1.48
0.60
1.2
1.1
—
—
—
0
0
63
730
0.86
0.55
2.1
1.6
4.12
4.57
mg/l
0.16
53
542
23
177
1.30
0.54
5.9
5.3
16.84
49.08
u/ml
—
9
58
6
38
1.58
0.54
1.0
1.1
25.75
43.49
iu/ml
—
6
38
28
223
1.26
0.52
1.4
1.6
—
—
—
0
0
9
63
1.43
0.52
1.3
1.4
10.13
9.04
ug/l
—
9
63
38
314
1.21
0.52
1.7
1.8
—
—
—
0
0
512
5342
0.95
0.52
4.4
4.6
22.59
21.66
%
0.72
255
2664
109
989
1.11
0.45
1.1
1.1
—
—
—
0
0
103
932
1.11
0.45
4.5
3.4
24.95
25.20
mmol/l
0.27
97
898
18
139
1.30
0.43
1.1
1.1
0.36
3.65
nmol/l
—
5
25
682
6626
1.04
0.39
5.5
5.6
3.89
2.73
ug/l
0.28
615
5989
39
335
1.17
0.38
1.5
1.6
—
—
—
0
0
12
91
1.32
0.33
1.3
1.4
—
—
—
0
0
6
88
0.68
0.33
1.2
1.6
—
—
—
0
0
40
351
1.14
0.32
1.6
1.6
—
—
—
0
0
30
260
1.16
0.28
1.6
1.3
34.06
25.35
u/l
0.54
22
216
7
91
0.77
0.22
1.7
1.2
11.57
9.15
mm/h
—
7
91
7
93
0.75
0.22
2.0
2.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
2.80
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
9.86
—
0
7
6
48
1.25
0.20
1.2
1.1
67.17
52.24
u/ml
—
6
48
65
609
1.07
0.18
1.7
1.5
—
—
—
0
0
10
121
0.83
0.18
2.0
1.4
208.51
161.49
pmol/l
—
10
121
456
4649
0.98
0.17
5.0
4.1
1.02
1.34
kg/l
0.50
348
3081
26
235
1.11
0.15
3.6
2.4
31.30
21.31
mg/l
—
10
90
30
278
1.08
0.12
1.1
1.0
5.24
2.66
eliau/ml
—
7
119
19
205
0.93
0.08
2.3
1.6
559.92
321.72
mu/l
1.63
13
170
11
114
0.96
0.00
1.1
1.8
—
—
—
0
0
397
3974
1.00
0.00
3.2
3.3
0.76
0.76
ug/l
0.01
268
2624
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
-0.00
1.0
1.0
1.57
14.93
u/ml
—
5
38
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1745.20
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint D3_OTHERWHITECELL and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_OTHERWHITECELL | 2.347 [2.09, 2.64] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.084 |
During the follow-up period (1.1.1998 — 31.12.2019), 1514 out of 5993 females with D3_OTHERWHITECELL died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_OTHERWHITECELL | 2.421 [2.12, 2.76] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 1770 out of 5506 males with D3_OTHERWHITECELL died.
Mortality risk
Mortality risk for people of age
years, who have D3_OTHERWHITECELL.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.184% | 0.514% |
| 5 | 1.121% | 2.821% |
| 10 | 3.172% | 6.665% |
| 15 | 6.287% | 12.13% |
| 20 | 10.342% | 20.488% |
Relationships between endpoints
↥Index endpoint: D3_OTHERWHITECELL – Other disorders of white blood cells
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data